Spero Therapeutics Inc (SPRO) Stock Price & News - Google Finance (2024)

Dow Jones38,778.10+0.49%+188.94Dow Jones38,778.100.49%
Nasdaq17,857.02+0.95%+168.14Nasdaq17,857.020.95%
Russell2,022.01+0.79%+15.85Russell2,022.010.79%
VIX12.75+0.71%+0.090VIX12.750.71%

HomeSPRO • NASDAQ

Spero Therapeutics Inc

$1.28

Jun 17, 5:20:00 PM GMT-4 · USD · NASDAQ · Disclaimer

Key events shows relevant news articles on days with large price movements

Key events shows relevant news articles on days with large price movements

Key events shows relevant news articles on days with large price movements

ROIV

$10.72

ROIV0.28%

SCYNEXIS Inc

$2.01

SCYX1.47%

MEI Pharma Inc

$2.88

MEIP0.69%

Avrobio Inc

$1.46

AVRO2.10%

Eagle Pharmaceuticals Inc

$4.06

EGRX5.45%

CytomX Therapeutics Inc

$1.37

CTMX0.72%

Companhia Energetica Minas Gerais ADR Repstg One Pref Shs

$1.82

CIG0.00%

AG Mortgage Investment Trust Inc

$6.91

MITT0.44%

BTCS Inc

$1.41

BTCS3.42%

Surgepays Inc

$3.73

SURG1.84%

Market news

.INX0.77%

S&P 500

.DJI0.49%

Dow Jones Industrial Average

Financials

Income Statement

Revenue

Net income

(USD)Mar 2024info

Fiscal Q1 2024 ended 3/31/24. Reported on 5/15/24.

Y/Y change

Revenue

The total amount of income generated by the sale of goods or services related to the company's primary operations

9.27M347.90%

Operating expense

Represents the total incurred expenses through normal operations

5.92M-19.13%

Net income

Company’s earnings for a period net of operating costs, taxes, and interest

-12.67M4.50%

Net profit margin

Measures how much net income or profit is generated as a percentage of revenue.

-136.7178.68%

Earnings per share

Represents the company's profit divided by the outstanding shares of its common stock.

-0.244.00%

EBITDA

Earnings before interest, taxes, depreciation, and amortization, is a measure of a company's overall financial performance and is used as an alternative to net income in some circ*mstances

-13.89M1.59%

Effective tax rate

The percent of their income that a corporation pays in taxes

Total assets

Total liabilities

(USD)Mar 2024info

Fiscal Q1 2024 ended 3/31/24. Reported on 5/15/24.

Y/Y change

Cash and short-term investments

Investments that are relatively liquid and have maturities between 3 months and one year

82.27M-14.53%

Total assets

The total amount of assets owned by a company

167.70M49.01%

Total liabilities

Sum of the combined debts a company owes

71.45M49.78%

Total equity

The value of subtracting the total liabilities from the total assets of a company

96.25M

Shares outstanding

Total number of common shares outstanding as of the latest date disclosed in a financial filing

53.99M

Price to book

A ratio used to determine if a company’s market value is in line with the value of its assets less liabilities and preferred stock

0.76

Return on assets

A financial ratio that shows a company’s profitability compared to its assets

-19.97%

Return on capital

Company’s return above the average cost it pays for its debt and equity capital

-32.68%

Net change in cash

(USD)Mar 2024info

Fiscal Q1 2024 ended 3/31/24. Reported on 5/15/24.

Y/Y change

Net income

Company’s earnings for a period net of operating costs, taxes, and interest

-12.67M4.50%

Cash from operations

Net cash used or generated for core business activities

5.94M146.20%

Cash from investing

Net cash used or generated in investing activities such as purchasing assets

Cash from financing

Net cash used or generated in financing activities such as dividend payments and loans

Net change in cash

The amount by which a company's cash balance increases or decreases in an accounting period

5.94M146.20%

Free cash flow

Amount of cash a business has after it has met its financial obligations such as debt and outstanding payments

-5.06M18.64%

Stock

Ownership of a fraction of a corporation and the right to claim a share of the corporation's assets and profits equal to the amount of stock owned

US listed security

Listed on NASDAQ

Previous close

The last closing price

$1.36

Day range

The range between the high and low prices over the past day

$1.25 - $1.35

Year range

The range between the high and low prices over the past 52 weeks

$0.99 - $1.89

Market cap

A valuation method that multiplies the price of a company's stock by the total number of outstanding shares.

69.10M USD

Avg Volume

The average number of shares traded each day over the past 30 days

162.29K

P/E ratio

The ratio of current share price to trailing twelve month EPS that signals if the price is high or low compared to other stocks

3.04

Dividend yield

The ratio of annual dividend to current share price that estimates the dividend return of a stock

-

Primary exchange

Listed exchange for this security

NASDAQ

About

CEO

Ankit Mahadevia

Founded

2013

Employees

46

Discover more

You may be interested in

info

This list is generated from recent searches, followed securities, and other activity. Learn more

All data and information is provided “as is” for personal informational purposes only, and is not intended to be financial advice nor is it for trading purposes or investment, tax, legal, accounting or other advice. Google is not an investment adviser nor is it a financial adviser and expresses no view, recommendation or opinion with respect to any of the companies included in this list or any securities issued by those companies. Please consult your broker or financial representative to verify pricing before executing any trades. Learn more

IndexDow Jones Industrial Average38,778.100.49%
TSLATesla Inc$187.445.30%
AAPLApple Inc$216.671.97%
AMZNAmazon.com Inc$184.060.22%
BABAAlibaba Group Holding Ltd - ADR$74.551.64%
MSFTMicrosoft Corp$448.371.31%
FFord Motor Co$11.851.15%
IndexVIX12.750.71%
IndexNasdaq Composite17,857.020.95%
NXSTNexstar Media Group Inc$151.910.90%
BABoeing Co$178.390.63%
DISWalt Disney Co$101.521.55%
NFLXNetflix Inc$675.830.96%
NVDANVIDIA Corp$130.980.68%
UALUnited Airlines Holdings Inc$50.361.35%
PFEPfizer Inc$26.982.00%

People also search for

ROIVROIV$10.720.28%
SCYXSCYNEXIS Inc$2.011.47%
MEIPMEI Pharma Inc$2.880.69%
AVROAvrobio Inc$1.462.10%
EGRXEagle Pharmaceuticals Inc$4.065.45%
CTMXCytomX Therapeutics Inc$1.370.72%
CIGCompanhia Energetica Minas Gerais ADR Repstg One Pref Shs$1.820.00%
MITTAG Mortgage Investment Trust Inc$6.910.44%
BTCSBTCS Inc$1.413.42%
SURGSurgepays Inc$3.731.84%
SPHRSphere Entertainment Co$34.490.26%
STRRStar Equity Holdings Inc$3.896.27%
SHENShenandoah Telecommunications Co$16.141.57%
TCRXTscan Therapeutics Inc$7.4411.43%
LXLexinFintech Holdings Ltd - ADR$1.681.51%
HOOKHookipa Pharma Inc$0.714.03%
IHiHuman Inc - ADR$1.967.69%
NCMINational CineMedia, Inc.$4.630.43%

Spero Therapeutics Inc (SPRO) Stock Price & News - Google Finance (7)HelpSend feedbackPrivacyTermsDisclaimer

Spero Therapeutics Inc (SPRO) Stock Price & News - Google Finance (2024)

References

Top Articles
Latest Posts
Article information

Author: Kerri Lueilwitz

Last Updated:

Views: 6199

Rating: 4.7 / 5 (47 voted)

Reviews: 86% of readers found this page helpful

Author information

Name: Kerri Lueilwitz

Birthday: 1992-10-31

Address: Suite 878 3699 Chantelle Roads, Colebury, NC 68599

Phone: +6111989609516

Job: Chief Farming Manager

Hobby: Mycology, Stone skipping, Dowsing, Whittling, Taxidermy, Sand art, Roller skating

Introduction: My name is Kerri Lueilwitz, I am a courageous, gentle, quaint, thankful, outstanding, brave, vast person who loves writing and wants to share my knowledge and understanding with you.